GILD - Arcus posts early-stage data for Gilead-partnered cancer therapy
2024-01-17 07:52:49 ET
More on Gilead, Arcus Biosciences, etc.
- Gilead Sciences, Inc. (GILD) JPMorgan 42nd Annual Healthcare Conference (Transcript)
- Gilead's Dividend Growth Potential Looks Phenomenal
- Without A Clear Growth Path, Gilead Sciences Is A Hold
- Gilead must face negligence claims over HIV drug development, court says
- Gilead in 2024: What to expect?
For further details see:
Arcus posts early-stage data for Gilead-partnered cancer therapy